SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Titan Biotech informs about record date

02 Jan 2026 Evaluate
Further to intimation dated November 29, 2025, regarding the approval of sub-division / split of equity shares by the Board of Directors of the Company, Titan Biotech has informed that pursuant to Regulation 42 of the Listing Regulations, the Company has fixed Friday, February 20, 2026, as the Record Date for the purpose of determining the eligibility of Members for the sub-division / Split of 1 equity share of face value of Rs 10 each, fully paid-up, into 5 equity shares of face value of Rs 2 each, fully paid-up as approved by the Members of the Company through Postal Ballot on December 30, 2025.

The above information is a part of company’s filings submitted to BSE.

Titan Bio-Tech Share Price

496.00 21.55 (4.54%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×